Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
November 3, 2021	4	Statement of changes in beneficial ownership of securities	0001562180-21-006801.pdf 0001562180-21-006801.rtf 0001562180-21-006801.xls View HTML
November 1, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-315574.pdf 0001193125-21-315574.rtf 0001193125-21-315574.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
October 1, 2021	4	Statement of changes in beneficial ownership of securities	0001562180-21-006188.pdf 0001562180-21-006188.rtf 0001562180-21-006188.xls View HTML
September 28, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-285489.pdf 0001193125-21-285489.rtf 0001193125-21-285489.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 9, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-268280.pdf 0001193125-21-268280.rtf 0001193125-21-268280.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 2, 2021	4	Statement of changes in beneficial ownership of securities	0001562180-21-005744.pdf 0001562180-21-005744.rtf 0001562180-21-005744.xls View HTML
August 24, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-254567.pdf 0001193125-21-254567.rtf 0001193125-21-254567.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2021	SC 13G/A	An amendment to the SC 13G filing	0000902219-21-000380.pdf 0000902219-21-000380.rtf 0000902219-21-000380.xls View HTML
August 5, 2021	8-K	Report of unscheduled material events or corporate event	0001193125-21-237047.pdf 0001193125-21-237047.rtf 0001193125-21-237047.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 5, 2021	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-21-015865.pdf 0001628280-21-015865.rtf 0001628280-21-015865.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax